Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

1.1K
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When Cancer Erupts: Recognizing the Volcano Lesion in Gastric Metastases.

ACG case reports journal·2025
Same author

An Unexpected Cause of Fistulizing Small Intestinal Disease.

Gastroenterology·2024
Same author

21-Year-Old Man With Fever, Jaundice, and Dark Urine.

Mayo Clinic proceedings·2024
Same author

Tirzepatide-Associated Colonic Ischemia.

ACG case reports journal·2024
Same author

An Alcohol-Associated Rash.

Gastroenterology·2024
Same author

75-Year-Old Woman With Abdominal Distention.

Mayo Clinic proceedings·2024
Same journal

Management of Common Bile Duct Stones: Current Approaches and Evolving Endoscopic Strategies.

Current gastroenterology reports·2026
Same journal

Solitary Rectal Ulcer Syndrome Revisited: A Comprehensive Narrative Review.

Current gastroenterology reports·2026
Same journal

The Microbiome and Esophageal Disease: Where Are We Now?

Current gastroenterology reports·2026
Same journal

Fermented Durian Tempoyak as a Source of Probiotics for Colorectal Cancer Prevention through Gut Microbiome Modulation.

Current gastroenterology reports·2026
Same journal

A Practical Guide to Incorporating Novel Barrett's Screening/Surveillance Tools into Clinical Practice.

Current gastroenterology reports·2026
Same journal

The Role of Endoscopic Ultrasound in the Diagnosis and Management of Congenital Gastrointestinal and Pancreaticobiliary Conditions.

Current gastroenterology reports·2026
See all related articles

Related Experiment Video

Updated: Mar 21, 2026

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

7.5K

Multi-Target Stool DNA Test: Is the Future Here?

Seth Sweetser1, David A Ahlquist2

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 55905, USA. sweetser.seth@mayo.edu.

Current Gastroenterology Reports
|May 12, 2016
PubMed
Summary
This summary is machine-generated.

The multi-target stool DNA (MT-sDNA) test is a highly accurate, non-invasive option for colorectal cancer (CRC) screening. This new method shows promise for increasing CRC screening participation and reducing incidence and mortality.

Keywords:
Colorectal cancerScreeningStool DNA

More Related Videos

A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model
08:14

A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model

Published on: February 28, 2018

9.4K
Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing
08:05

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing

Published on: March 19, 2018

20.8K

Related Experiment Videos

Last Updated: Mar 21, 2026

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

7.5K
A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model
08:14

A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model

Published on: February 28, 2018

9.4K
Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing
08:05

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing

Published on: March 19, 2018

20.8K

Area of Science:

  • Oncology
  • Gastroenterology
  • Preventive Medicine

Background:

  • Colorectal cancer (CRC) screening significantly reduces incidence and mortality but faces low uptake.
  • A substantial portion of the population remains unscreened despite established benefits.

Purpose of the Study:

  • To review the current knowledge on the multi-target stool DNA (MT-sDNA) test for colorectal cancer screening.
  • To highlight the potential of MT-sDNA tests to improve screening adherence.

Main Methods:

  • Literature review of existing studies on MT-sDNA tests for CRC screening.
  • Analysis of MT-sDNA test accuracy in detecting colorectal neoplasia.
  • Assessment of MT-sDNA's role in enhancing screening uptake.

Main Results:

  • The MT-sDNA test demonstrates high accuracy in detecting colorectal neoplasia.
  • This non-invasive screening option presents a significant opportunity to increase CRC screening rates.
  • Current data supports MT-sDNA as an effective tool in CRC screening strategies.

Conclusions:

  • The MT-sDNA test is a valuable, accurate, and non-invasive tool for colorectal cancer screening.
  • Its implementation can potentially improve screening adherence and reduce CRC burden.
  • Further research and clinical integration of MT-sDNA are warranted.